Global Veterinary Infectious Disease Diagnostics Market Size, Share, Analysis, Growth, 2032

Veterinary Infectious Disease Diagnostics Industry Perspective

What will be the global Veterinary Infectious Disease Diagnostics market size during the forecast period?

The global veterinary infectious disease diagnostics market size accrued earnings worth approximately USD 7.12 billion in 2023 and is predicted to gain revenue of about USD 15.17 billion by 2032, and is set to record a CAGR of nearly 8.76% over the period from 2024 to 2032.

This report provides a comprehensive analysis of the growth drivers, restraints, and challenges shaping demand across the global veterinary infectious disease diagnostics market throughout the forecast period, while highlighting high-potential emerging opportunities within the industry.

Request Free Sample

Key Insights

• As per the analysis shared by our research analyst, the global Veterinary Infectious Disease Diagnostics market is estimated to grow annually at a CAGR of around 8.76% over the forecast period (2024-2032).
• In terms of revenue, the global Veterinary Infectious Disease Diagnostics market size was valued at around USD 7.12 billion in 2023 and is projected to reach USD 15.17 billion by 2032.
• The market is driven by the increasing prevalence of infectious diseases in animals, growing pet ownership and expenditure on veterinary care, and continuous technological advancements in diagnostic platforms.
• Based on the technology, immunodiagnostics dominated the market owing to its cost-effectiveness, high accuracy, and widespread adoption of ELISA
• Based on the animal type, the companion animals segment held the largest market share in 2023 and is expected to grow at a significant rate over the forecast period
• Based on the end-user, the reference laboratories segment is growing at a high rate and is projected to dominate the global market
• Based on the region, North America dominated the market with a significant share driven by advanced veterinary infrastructure, high pet ownership rates, and strong presence of key industry players

Veterinary Infectious Disease Diagnostics Market: Overview

The Veterinary Infectious Disease Diagnostics Market is a specialized segment within the veterinary healthcare industry focused on the development, production, and distribution of diagnostic tools and tests used to detect infectious diseases in animals. This market addresses the growing need for accurate and timely diagnosis of diseases in livestock, pets, and wildlife, helping to prevent and control outbreaks. It encompasses various diagnostic technologies, including PCR, ELISA, and rapid tests, which enable veterinarians to identify pathogens and infections, ensuring effective treatment and management. The market is driven by increasing pet ownership, rising awareness of animal health, technological advancements, and the need for early detection of zoonotic diseases that can impact both animals and humans.

Veterinary Infectious Disease Diagnostics Market: Growth Factors

What factors are primarily accelerating demand for veterinary infectious disease diagnostics?

The increasing prevalence of infectious diseases among livestock, companion animals, and wildlife is a major driver of the market. Diseases such as avian influenza, canine parvovirus, and bovine tuberculosis require timely and accurate diagnostics to prevent outbreaks, driving demand for advanced diagnostic tools. The surge in pet ownership, particularly in developed regions, is fueling the demand for veterinary care, including diagnostics. Pet owners are increasingly willing to spend on the health and well-being of their animals, leading to higher demand for veterinary infectious disease diagnostics.

Innovations in diagnostic technologies, such as PCR, ELISA, and next-generation sequencing (NGS), have enhanced the accuracy, speed, and ease of diagnosing infectious diseases in animals. These advancements are helping veterinarians to identify and treat infections more effectively, contributing to market growth.

Restraints

What challenges could limit the expansion of the veterinary infectious disease diagnostics market?

High costs associated with advanced diagnostic instruments and specialized reagents can restrict adoption, particularly among smaller veterinary clinics and in price-sensitive emerging markets. Limited access to sophisticated laboratory infrastructure in certain regions further constrains market penetration.

Additionally, the shortage of trained veterinary professionals and diagnostic technicians in some geographies slows the effective utilization of advanced testing platforms. Regulatory complexities surrounding the approval and commercialization of new diagnostic assays can also delay product launches and increase development timelines for manufacturers.

Request Free Sample

Veterinary Infectious Disease Diagnostics Market: Report Scope

Veterinary Infectious Disease Diagnostics Market: Segmentation

The study provides a decisive view of the Veterinary Infectious Disease Diagnostics market by segmenting the market based on technology, animal type, end-user, and region.

Based on technology, the market is divided into Immunodiagnostics, Molecular Diagnostics, and Other Veterinary Diagnostic Technologies. The Immunodiagnostics segment is sub-segmented into Lateral Flow Assays, ELISA Tests, and Other Immunodiagnostic Technologies. The Molecular Diagnostics segment is sub-segmented into Polymerase Chain Reaction (PCR) Tests, Microarrays, and Other Molecular Diagnostic Tests.

Based on the animal type, the market is segmented into Companion Animals and Food Producing Animals. Companion Animals constitute the dominant segment, fueled by rising pet ownership, higher rates of medicalization, and increasing willingness of owners to invest in advanced diagnostic care for dogs, cats, and other pets. The emotional and financial commitment to companion animal health translates into frequent testing for infectious diseases, supporting consistent demand for both in-clinic and laboratory-based diagnostics and anchoring a substantial share of market revenue.

Based on End Users Segment, the Veterinary Infectious Disease Diagnostics market is divided into Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care/In-House Testing, and Research Institutes and Universities. Reference Laboratories hold the leading position due to their advanced instrumentation, specialized expertise, and capacity to process high volumes of complex molecular and specialized assays. These facilities serve as critical hubs for confirmatory testing and large-scale surveillance programs, generating significant testing volumes and supporting market growth through consistent demand for high-performance reagents and systems.

Veterinary Infectious Disease Diagnostics Market: Regional Analysis

Why will North America continue to dominate the global market during the projection period?

North America maintains a leading position in the global veterinary infectious disease diagnostics market, supported by a mature veterinary healthcare infrastructure, high rates of pet ownership, and substantial expenditure on animal health. The United States, in particular, benefits from a dense network of veterinary clinics, reference laboratories, and research institutions, alongside a strong presence of major diagnostic companies. Elevated awareness among pet owners regarding preventive care and early disease detection, combined with robust livestock surveillance programs, sustains high testing volumes. Continuous technological adoption, favorable reimbursement and insurance trends for companion animals, and active regulatory support for animal health further reinforce the region’s dominance and influence global product development and commercialization strategies.

Europe follows as a significant market, characterized by stringent animal welfare regulations, advanced diagnostic capabilities, and high standards of veterinary practice. Countries such as Germany, the United Kingdom, and France contribute meaningfully through well-established laboratory networks and growing emphasis on zoonotic disease monitoring.

Veterinary Infectious Disease Diagnostics Market:  Competitive Analysis

The global Veterinary Infectious Disease Diagnostics market is dominated by players:

• IDEXX Laboratories, Inc.
• Zoetis. Inc.
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Neogen Corporation
• Virbac
• BioMérieux SA
• IDVet
• Randox Laboratories Ltd.
• Heska Corporation
• Creative Diagnostics
• Eurofins Technologies 

This report segments the global Veterinary Infectious Disease Diagnostics market as follows:

By Technology

• Immunodiagnostics
  • Lateral Flow Assays
  • ELISA Tests
  • Other Immunodiagnostic Technologies
• Molecular Diagnostics
  • Polymerase Chain Reaction (PCR) Tests
  • Microarrays
  • Other Molecular Diagnostic Tests
• Other Veterinary Diagnostic Technologies

By Animal Type

• Companion Animals
• Food Producing Animals

By End Users

• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care / In-House Testing
• Research Institutes and Universities

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America